Asset Management

Visium insider trading case ensnares former FDA official

A hedge fund insider-trading case has ensnared a former Food and Drug Administration official, one of the first criminal actions focused on how Wall Street gathers information from Washington.

A hedge fund insider-trading case has ensnared a former Food and Drug Administration official, one of the first criminal actions focused on how Wall Street gathers information from Washington.

Federal prosecutors on June 15 unveiled charges against a current and a former portfolio manager of hedge- fund firm Visium Asset Management, accusing them of trading on confidential government information about generic-drug approvals.

WSJ Logo
Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With TrumpExternal link

Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With Trump